# Reviva Pharmaceuticals Holdings, Inc.: filings

RVPH · OTC · CIK 1742927 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rvph.md) · [Financials](/companies/rvph/financials.md) · [Filings](/companies/rvph/filings.md) · [Insiders](/companies/rvph/insiders.md)

## Reports and events: 172 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 94, 4 63, 10-Q 25, 3 19, 424B3 14, 424B5 13, CORRESP 13, EFFECT 12, SC 13D/A 12, UPLOAD 11, 425 10, SC 13G 10, SC 13G/A 9, SCHEDULE 13G/A 9, 10-K 8, DEF 14A 8, SCHEDULE 13D/A 8, 424B4 7, PRE 14A 6, S-1/A 6, SCHEDULE 13G 6, POS AM 5, S-8 5, S-1 4, 25-NSE 3, 8-K/A 3, ARS 3, DEFA14A 3, S-4/A 3, 10-K/A 2, NT 10-K 2, S-1MEF 2, S-3 2, SC 13D 2, 8-A12B 1, CERT 1, D 1, DRS 1, POS EX 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 16:53 ET | [10-Q](/filings/0001437749-26-027358.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027358 |
| 2026-08-12 | 16:52 ET | [8-K](/filings/0001437749-26-027356.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027356 |
| 2026-05-13 | 16:43 ET | [10-Q](/filings/0001437749-26-016762.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016762 |
| 2026-05-13 | 16:41 ET | [8-K](/filings/0001437749-26-016760.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-016760 |
| 2026-05-13 | 08:03 ET | [8-K](/filings/0001437749-26-016538.md) | 3.01 Delisting notice; 8.01 Other events | 0001437749-26-016538 |
| 2026-04-15 | 08:05 ET | [8-K](/filings/0001437749-26-012303.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-012303 |
| 2026-03-30 | 06:11 ET | [8-K](/filings/0001437749-26-010140.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-010140 |
| 2026-03-30 | 20:58 ET | [10-K](/filings/0001437749-26-010126.md) | Annual report, period 2025-12-31 | 0001437749-26-010126 |
| 2026-03-24 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001493152-26-012362.md) | Ownership report, active investor, amended | 0001493152-26-012362 |
| 2026-03-19 | 16:17 ET | [8-K](/filings/0001437749-26-009063.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-009063 |
| 2026-03-05 | 08:00 ET | [8-K](/filings/0001437749-26-006991.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-006991 |
| 2026-01-23 | 16:15 ET | [8-K](/filings/0001437749-26-001913.md) | 3.01 Delisting notice; 8.01 Other events | 0001437749-26-001913 |
| 2025-12-23 | 08:05 ET | [8-K](/filings/0001437749-25-038602.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038602 |
| 2025-12-22 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001493152-25-028783.md) | Ownership report, active investor, amended | 0001493152-25-028783 |
| 2025-11-13 | 16:19 ET | [8-K](/filings/0001437749-25-034846.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034846 |
| 2025-11-13 | 16:11 ET | [10-Q](/filings/0001437749-25-034827.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034827 |
| 2025-11-04 | 16:16 ET | [DEF 14A](/filings/0001437749-25-033023.md) | Proxy statement, period 2025-12-18 | 0001437749-25-033023 |
| 2025-10-17 | 16:31 ET | [8-K](/filings/0001437749-25-031278.md) | 3.01 Delisting notice | 0001437749-25-031278 |
| 2025-09-26 | 17:10 ET | [8-K](/filings/0001437749-25-029951.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-25-029951 |
| 2025-09-24 | 16:33 ET | [SCHEDULE 13D/A](/filings/0001437749-25-029807.md) | Ownership report, active investor, amended | 0001437749-25-029807 |
| 2025-09-24 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001493152-25-014806.md) | Ownership report, active investor, amended | 0001493152-25-014806 |
| 2025-09-19 | 17:27 ET | [8-K](/filings/0001437749-25-029531.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029531 |
| 2025-08-14 | 16:35 ET | [8-K](/filings/0001437749-25-026971.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-026971 |
| 2025-08-14 | 16:32 ET | [10-Q](/filings/0001437749-25-026967.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026967 |
| 2025-07-01 | 18:40 ET | [SCHEDULE 13D/A](/filings/0001641172-25-017411.md) | Ownership report, active investor, amended | 0001641172-25-017411 |
| 2025-07-01 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001437749-25-021746.md) | Ownership report, active investor, amended | 0001437749-25-021746 |
| 2025-06-26 | 17:21 ET | [8-K](/filings/0001437749-25-021361.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-021361 |
| 2025-06-06 | 16:06 ET | [8-K](/filings/0001437749-25-019716.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-019716 |
| 2025-06-02 | 07:05 ET | [8-K](/filings/0001437749-25-019062.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019062 |
| 2025-05-30 | 16:09 ET | [8-K](/filings/0001437749-25-018972.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-018972 |
| 2025-05-15 | 16:16 ET | [10-Q](/filings/0001437749-25-017191.md) | Quarterly report, period 2025-03-31 | 0001437749-25-017191 |
| 2025-05-15 | 16:10 ET | [8-K](/filings/0001437749-25-017185.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-017185 |
| 2025-04-03 | 19:47 ET | [10-K](/filings/0001437749-25-010791.md) | Annual report, period 2024-12-31 | 0001437749-25-010791 |
| 2025-03-31 | 16:12 ET | [8-K](/filings/0001437749-25-010191.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-010191 |
| 2025-02-18 | 16:32 ET | [8-K](/filings/0001437749-25-004224.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-004224 |
| 2025-01-31 | 21:31 ET | [SCHEDULE 13D/A](/filings/0001493152-25-004530.md) | Ownership report, active investor, amended | 0001493152-25-004530 |
| 2024-12-20 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001437749-24-038128.md) | Ownership report, active investor, amended | 0001437749-24-038128 |
| 2024-12-18 | 19:20 ET | [8-K](/filings/0001437749-24-037764.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-037764 |
| 2024-12-16 | 08:10 ET | [8-K](/filings/0001437749-24-037520.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-037520 |
| 2024-12-12 | 16:36 ET | [8-K](/filings/0001437749-24-037373.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-037373 |
| 2024-11-14 | 17:25 ET | [8-K](/filings/0001437749-24-035391.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035391 |
| 2024-11-14 | 17:15 ET | [10-Q](/filings/0001437749-24-035375.md) | Quarterly report, period 2024-09-30 | 0001437749-24-035375 |
| 2024-11-12 | 08:30 ET | [8-K](/filings/0001437749-24-034338.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034338 |
| 2024-10-28 | 16:17 ET | [DEF 14A](/filings/0001437749-24-032297.md) | Proxy statement, period 2024-12-10 | 0001437749-24-032297 |
| 2024-09-17 | 17:21 ET | [8-K](/filings/0001437749-24-029392.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-029392 |
| 2024-08-23 | 16:07 ET | [SC 13D/A](/filings/0001437749-24-027668.md) | Ownership report, active investor, amended | 0001437749-24-027668 |
| 2024-08-23 | 16:06 ET | [SC 13D/A](/filings/0001437749-24-027667.md) | Ownership report, active investor, amended | 0001437749-24-027667 |
| 2024-08-22 | 17:04 ET | [8-K/A](/filings/0001437749-24-027621.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027621 |
| 2024-08-21 | 17:16 ET | [8-K](/filings/0001437749-24-027511.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027511 |
| 2024-08-14 | 08:15 ET | [10-Q](/filings/0001437749-24-026571.md) | Quarterly report, period 2024-06-30 | 0001437749-24-026571 |

Page 1 of 4. [Older](/companies/rvph/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:33 ET. No prices; not investment advice.